Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 196, pseudogene (RN7SL196P) is a locus on chromosome 15 that represents a *pseudogene* derived from the 7SL RNA family[6][7]. 7SL RNA is a non-coding RNA component of the signal recognition particle (SRP), essential for protein targeting to the endoplasmic reticulum[3][5]. However, RN7SL196P is a *pseudogene*—it is a non-functional, truncated copy that does not encode a functional RNA or protein, and is not known to have direct biological or clinical roles. Most human 7SL RNA-related sequences are pseudogenes, typically generated by retrotransposition events, and while some pseudogenes may act as regulatory RNAs in certain contexts, there is *no evidence for functional, disease, or drug-related relevance for RN7SL196P specifically*[1][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 196, pseudogene (RN7SL196P).